Development and characterization of a murine monoclonal antibody reactive with a 64 kDa somatic antigen of Burkholderia cepacia

Hybridoma

Volumn 17, Issue 2, 1998, Pages 143-150

  Otterbein, C K ^a   Splettstoesser, W D ^a   Linde, H J ^b   Grunow, R ^a   Wolf, H ^b   Finke, E J ^a   Neubauer, H ^a  

^a FAF Medical Academy   (Germany)

^b UNIVERSITY OF REGENSBURG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

MONOCLONAL ANTIBODY;

ANIMAL CELL; ANTIBODY RESPONSE; ANTIBODY SPECIFICITY; ANTIGEN DETECTION; ARTICLE; BURKHOLDERIA CEPACIA; CROSS REACTION; CYSTIC FIBROSIS; DNA PROBE; ENZYME LINKED IMMUNOSORBENT ASSAY; HOSPITAL INFECTION; HYBRIDOMA; IMMUNE DEFICIENCY; MOUSE; NONHUMAN; PRIORITY JOURNAL;

ANIMALIA; BURKHOLDERIA; BURKHOLDERIA CEPACIA; BURKHOLDERIA GLADIOLI; BURKHOLDERIA MALLEI; BURKHOLDERIA PSEUDOMALLEI; MURINAE; PSEUDOMONAS; PSEUDOMONAS AERUGINOSA;

EID: 0031805002     PISSN: 0272457X     EISSN: None     Source Type: Journal    
DOI: 10.1089/hyb.1998.17.143     Document Type: Article

References (40)

1. Yabuuchi E, Kosako Y, Oyaizu H, Yano I, Hotta H, Hashimoto Y, Ezaki T, and Arakawa M: Proposal of Burkholderia gen. nov. and transfer of seven species of the genus Pseudomonas homology group II to the new genus, with the type species Burkholderia cepacia (Palleroni and Holmes 1981) comb. nov. Microbiol Immunol 1992;36:1251-1275.
2. Palleroni NJ, and Holmes B: Pseudomonas cepacia sp. nov., nom. rev. Int J Syst Bacteriol 1981;31:479-481.
3. Burkholder WH: Sour skin, a bacterial rot of onion bulbs. Phytopathology 1950;40:115-117.
4. Prince A: Antibiotic resistance of Pseudomonas species. J Pediatr 1986;108:830-834.
5. Bosso JA, Saxon BA, and Matsen JM: Comparative activity of cefepine, alone and in combination, against clinical isolates of Pseudomonas aeruginosa and Pseudomonas cepacia from cystic fibrosis patients. Antimicrobial Agents Chemotherapy 1991; 35:783-784.
6. Allison DG, and Matthews MJ: Effect of polysaccharide interactions on antibiotic susceptibility of Pseudomonas aeruginosa. J Appl Bacteriol 1992;73:371-376.
7. Lewin C, Doherty C, and Govan JRC: In vitro activities of meropenem, PD 127391, PD 131628, ceftazidime, chloramphenicol, cotrimoxazole, and ciprofioxacin against Pseudomonas cepacia. Antimicrob Agents Chemother 1993;37:123-125.
8. McKenney D, Willcock L, Trueman PA, and Allison DG: Effect of sub-MIC antibiotics on the cell surface and extracellular virulence determinants of Pseudomonas cepacia. J Appl Bacteriol 1994;76:190-195.
9. Simpson IN, Finlay J, Winstanley DJ, Dewhurst N, Nelson JW, Butler SL, and Govan JRW: Multiresistance isolates possessing characteristics of both Burkholderia (Pseudomonas) cepacia and Burkholderia gladioli from patients with cystic fibrosis. J Antimicrob Chemother 1994;34:353-361.
10. Bottone EJ, Douglas SD, Rausen AR, and Keusch GT: Association of Pseudomonas cepacia with chronic granulomatous disease. J Clin Microbiol 1975;1:425-428.
11. Dailey RH, and Benner EJ: Necrotizing pneumonitis due to the Pseudomonad "Eugenic Oxidizer-Group I." N Engl J Med 1968;279:361-362.
12. Rosenstein BJ, and Hall DE: Pneumonia and septicemia due to Pseudomonas cepacia in a patient with cystic fibrosis. The John Hopkins Medical Journal 1980;147:188-189.
13. Isles A, Maclusky I, Corey M, Gold R, Prober C, Fleming P, and Levison H: Pseudomonas cepacia infection in cystic fibrosis: An emerging problem. J Pediatr 1984;104:206-210.
14. Gilligan PH: Microbiology of airway disease in patients with cystic fibrosis. Clin Microbiol Rev 1991;4:35-51.
15. Govan JRW, Brown PH, Maddison J, Doherty CJ, Nelson JW, Dodd M, Greening AP, and Webb AK: Evidence for transmission of Pseudomonas cepacia by social contact in cystic fibrosis. Lancet 1993;342:15-19.
16. Smith DL, Gumery LB, Smith EG, Stableforth DE, Kaufmann ME, and Pitt TL: Epidemic of Pseudomonnas cepacia in an adult cystic fibrosis unit: Evidence of person-to-person transmission. J Clin Microbiol 1993;31:3017-3022.
17. Govan JRW, and Deretic V: Microbial pathogenesis in cystic fibrosis: Mucoid Pseudomonas aeruginosa and Burkholderia cepacia. Microbiol Rev 1996;60:539-574.
18. Taylor PC, and Kalamatianos CC: Pseudomonas cepacia in the sputum of cystic fibrosis patients. Pathology 1994;26:315-317.
19. Kiska DL, Kerr A, Jones MC, Caracciolo JA, Eskridge B, Jordan M, Miller S, Hughes D, King N, and Gilligan P: Accuracy of four commercial systems for identification of Burkholderia cepacia and other gram-negative nonfermenting bacilli recovered from patients with cystic fibrosis. J Clin Microbiol 1996;34:886-891.
20. Dasen SE, LiPuma JJ, Kostman JR, and Stull TL: Characterization of PCR-Ribotyping for Burkholderia (Pseudomonas) cepacia. J Clin Microbiol 1994;32:2422-2424.
21. Rodley PD, Römling U, and Tümmler B: A physical genome map of the Burkholderia cepacia type strain. Mol Microbiol 1995;17:57-67.
22. Cazzola G, Amalfitano G, Tonolli E, Perazzoli C, Piacentini I, and Mastella G: Burkholderia (Pseudomonas) cepacia epidemiology in a cystic fibrosis population: A genome finger-printing study. Acta Paediatr 1996;85:554-557.
23. Valcin M, Moissenet D, Sardet A, Tournier G, Garbarg-Chenon A, and Vu-Thien H: Pseudomonas (Burkholderia) cepacia in children with cystic fibrosis: Epidemiological investigations by analysis of restriction fragment length polymorphism. Path Biol 1996;44:442-446.
24. Kooi C, Cox A, Darling P, and Sokol PA: Neutralizing monoclonal antibodies to an extracellular Pseudomonas cepacia protease. Infect Immun 1994;62:2811-2817.
25. Kearney JF, Radbruch A, Liesegang B, and Rajewski K: A new mouse myeloma cell line that has lost immunoglobulin expression but permits the construction of antibody-secreting hybrid cell lines. J Immunol 1975;123:1548-1550.
26. Peters JH: Fusing cells to generate mouse monoclonal antibodies. In: Monoclonal Antibodies. Peters JH, and Baumgarten H (Eds.). Springer-Verlag, New York, 1992, pp. 149-157.
27. Hanks JH, and Wallace JA: Determination of cell viability. Proc Soc Exp Biol Med 1958;98:188.
28. Steinmetz I, Rohde M, and Brenneke B: Purification and characterization of an exopolysaccharide of Burkholderia (Pseudomonas) pseudomallei. Infect Immun 1995;63:3959-3965.
29. Rugdech P, Anuntagool N, and Sirisinha S: Monoclonal antibodies to Pseudomonas pseudomallei and their potential for diagnosis of melioidosis. Am J Trop Med Hyg 1995;52:231-235.
30. Anuntagool A, Intachote P, Naigowit P, and Sirisinha S: Rapid antigen detection assay for identification of Burkholderia (Pseudomonas) pseudomallei infection. J Clin Microbiol 1996;34:975-976.
31. Heidt A, Monteil H, and Richard C: O and H serotyping of Pseudomonas cepacia. J Clin Microbiol 1983;18:738-740.
32. McKewitt AI, Retzer MD, and Woods DE: Development and use of a serotyping scheme for Pseudomonas cepacia. Serodiagn Immunother 1987;1:177-184.
33. Werneburg B, and Monteil H: New serotypes of Pseudomonas cepacia. Res Microbiol 1989;140:17-20.
34. Yabuuchi E, Kosako Y, Yano I, Hotta H, and Nishiuchi Y: Transfer of two Burkholderia and an Alcaligenes species to Ralstonia gen. nov.: Proposal of Ralstonia pickettii (Ranston, Palleroni, and Doudoroff, 1973) comb, nov., Ralstonia solanacearum (Smith, 1896) comb. nov. and Ralstonia eutropha (Davis 1969) comb. nov. Microbiol Immunol 1995;39:897-904.
35. Urakami T, Ito-Yoshida C, Araki H, Kijima T, Suzuki K-I, and Komagata K: Transfer of Pseudomonas plantarii and Pseudomonas glumae to Burkholderia as Burkholderia spp. and description of Burkholderia vandii sp. nov. Int J Syst Bacteriol 1994;44:235-245.
36. 2-fixing isolates from rice in Vietnam. Int J Syst Bacteriol 1995;45:274-289.
37. Christenson JC, Welch DF, Mukwaya G, Muszynski MJ, Weaver RE, and Brenner DJ: Recovery of Pseudomonas gladioli from respiratory trace specimens of patients with cystic fibrosis. J Clin Microbiol 1989;27:270-273.
38. Bernstein JM, and Carling ER: Observations on human glanders. Brit Med J 1909;1:319-323.
39. FAO: In: Animal health yearbook. Rome 1997:102.
40. Yabuuchi E, and Arakawa M: Burkholderia pseudomallei and melioidosis: Be aware in temperate area. Microbiol Immunol 1993;37:823-836.